Newsroom

2001 News Releases

  • Emory Eye Center again in Ophthalmology Times National Rankings
    The Emory Eye Center has again landed in Ophthalmology Times’ top ten rankings for national ophthalmic programs. Ophthalmology Times is a semi-monthly newspaper written and reviewed by ophthalmologists. The Eye Center was ranked in the Nov. 1 issue under the category “Best Overall Program” as eighth (the same as last year), in “Best Clinical (patient care) Programs” as seventh (a new ranking for the Eye Center) and as sixth in the category “Best Residency Programs” (same as last year).
    November 16, 2001

  • How Diabetes Can Adversely Affect Your Eyes
    November 1-30 is Diabetic Eye Disease Awareness Month. Many are unaware that diabetes can lead to vision loss when untreated. Ophthalmologists at the Emory Eye Center routinely treat patients who have the particular complications of diabetes that affect their vision. Diabetic retinopathy is a complication of diabetes, which can weaken the retina and block, distort or blur vision. While no one knows why diabetes sometimes causes abnormal blood vessels to form in the back of the eye, current research is providing some answers. With diabetic retinopathy these new vessels can leak fluid into the retina or vitreous humor (the jelly that fills the eye) and contract, distort or detach the retina. November 2, 2001

  • Important Findings from National AREDS Study: Macular Degeneration: Progression Can Be Slowed for Those at High Risk
    Findings were released today detailing the results of an important 10-year study which had a two-fold purpose: To assess the clinical course, prognosis, and risk factors of age-related macular degeneration (AMD) and cataract; and to evaluate, in randomized clinical trials, the effects of pharmacologic doses of antioxidants and zinc on the progression of AMD and antioxidants on the development and progression of lens opacities (cataract). Titled Age- Related Eye Disease Study (AREDS), the clinical trial was conducted at 11 centers across the country, including the Emory Eye Center. Oct. 12, 2001

  • Neuro-Ophthalmology 2001 in December: A Post-Graduate Course for Physicians
    The Emory Eye Center in Atlanta will host Neuro-Ophthalmology 2001, a conference designed for ophthalmologists, neurologists, neurosurgeons and any physicians interested in an update in neuro-ophthalmology, all day Friday, Dec. 7, 2001 at the Emory Conference Center Hotel. October 1, 2001

  • Researcher finds similar survival rates for eye cancer therapies
    The National Eye Institute (NEI) has issued important research results stating that survival rates for two alternative treatments for primary eye cancer—radiation therapy and removal of the eye—are about the same. Emory Eye Center’s Paul Sternberg, Jr., M.D., was a primary investigator in the nationwide study, with results announced July 12. The clinical trial—called the Collaborative Ocular Melanoma Study (COMS)––was conducted at 43 institutions, including medical schools, hospitals, and doctors' offices, throughout the United States and Canada. The COMS trial was supported by the NEI and the National Cancer Institute (NCI), components of the National Institutes of Health (NIH). Prior to these findings, it was not known which treatment could result in lower mortality rates. Additionally, as a result of the study, the capability of doctors to provide more accurate diagnoses and state-of-the-art treatments for eye cancer has been greatly expanded, the findings report. Mortality data from the two treatments are compared in the July 2001 issue of Archives of Ophthalmology. July 31, 2001

  • Treat Contact Lenses with the respect they deserve
    Just because contact lenses are easily accessible and affordable these days doesn’t mean they should be treated as cosmetic items, says a contact lens specialist at the Emory Eye Center. Because of massive advertising campaigns by contact lens manufacturers in the past, many have come to think of contact lenses as beauty and lifestyle enhancements instead of the medical devices that they are. We can change our eye color at will with a choice of lenses widely available in shades of lavender, green, brown, blue and more. July 9, 2001

  • Media Advisory: Emory Eye Center hosts annual picnic for children treated for Retinoblastoma on Saturday (9 a.m. to 1 p.m.)
    The Emory Eye Center's ocular oncology section will host its annual springtime picnic for children treated at Emory for retinoblastoma (RB), a hereditary retinal tumor that affects mainly children. With new treatment, called transpupillary thermotherapy (TPTT), most of the children affected with RB have a good prognosis today, especially if detected in the early stages. May 9, 2001

  • New Generation of Vision-Enhancing System Offers Independence to Individuals with Low Vision
    The second generation of a popular and seemingly amazing low vision device has recently come on the market, according to Emory Eye Center's Director of Low Vision, Dr. Ned Witkin. Named the "Jordy" (v.2.0), the newest version offers several improvements over last year's debut model. "This is the most exciting advancement we've had in technology for the visually impaired in years," says Dr. Witkin. April 24, 2001

  • Emory Eye Center receives core grant providing 20 consecutive years of funding
    Henry Edelhauser, Ph.D., director of research at the Emory Eye Center, and his colleagues have received $1.5 million in research dollars through the National Eye Institute (NEI), a division of the National Institutes of Health (NIH). The grant covers a five-year period, beginning in April. The NEI Core Center Grant includes three modules: 1) Structural Biology; 2) Analytical Biochemistry/Molecular Biology; and 3) Epidemiology and Biostatistics. Emory Eye Center's past Core Center Grant has successfully supported collaborative vision research and service, involving some 33 faculty (including more than 20 NEI-funded principal investigators), 20 postdoctoral fellows, six pre-doctoral fellows and generated more than 250 publications over the past five years. March 19, 2001

  • Emory researcher reveals effect of Lasik Surgery on Cornea three years following the procedure
    Emory Eye Center researcher Henry Edelhauser, Ph.D. and co-workers have completed a three-year study on Emory University Eye Center patients who underwent a laser in situ keratomileusis (LASIK) procedure, a refractive surgery to correct eyesight. The patients were evaluated to ascertain the long-term effects of such surgery on the corneal endothelium, the cells that line the inside of the cornea. Sometimes referred to as the "window to the world," the cornea is the transparent covering over the eye. March 13, 2001

  • Emory Medical School student awarded RPB funding to take a year off and do research at Emory Eye Center
    Not many medical students take a year off to enrich their education with research, but that's just what Emory University third-year medical student Chirag Parikh did in order to work with Emory Eye Center researcher Henry Edelhauser, Ph.D. Under the guidance of Dr. Edelhauser, whose expertise is corneal research, Parikh has found a second home, at least for this year. February 1, 2001

  • Study at Emory Eye Center provides new hope for nearsighted children
    An experimental new drug is providing some hope that in the future, preventing the typical progression of myopia, or nearsightedness, in children may be possible. In other words, children who become nearsighted early may not have to endure stronger and stronger glasses or contact lenses to treat their vision problem. That nearsightedness could be halted in an early stage. January 22, 2001

Our Emory campus location:

Copyright © Emory Eye Center - All Rights Reserved | Emory Clinic Building B, 1365B Clifton Road, NE, Atlanta, Georgia 30322 USA